Stage IV Bladder Urothelial Carcinoma AJCC v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
DB11794 | Berzosertib | 2 | Active Not Recruiting | 1 |
DB14547 | Chloride ion | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB09035 | Nivolumab | 2 | Completed | 1 |
DB12257 | Platinum | 2 | Active Not Recruiting | 1 |
DB11836 | Sapanisertib | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 3 | Completed | 1 |
DB14547 | Chloride ion | 3 | Completed | 1 |
DB00515 | Cisplatin | 3 | Completed | 1 |
DB00441 | Gemcitabine | 3 | Completed | 1 |
DB09035 | Nivolumab | 3 | Recruiting | 1 |
DB12257 | Platinum | 3 | Completed | 1 |
DB14851 | Relatlimab | 3 | Recruiting | 1 |